Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by TheBearInTheWoodson May 22, 2020 7:38pm
123 Views
Post# 31063342

RE:RE:RE:RE:Trading below PP

RE:RE:RE:RE:Trading below PP  "As far as who owns what, insider this and that, it all comes out in the rinse."

Your name clearly indicates your bias in this play and thats fine, but my post was educate shareholders that management owns a handful of shares. If management owned shares they would not have made terrible market decsions which they did, Maybe the team arent market people, but they brought a share price from .58 to .35 with now 40 million warrants, As much as you want to compare to BLU because your looking to be in their footsteps.Management didnt buy shares at .03 but they sure diluted at .35 becuase it pays their salary. You dont need to be defensive of other companies, They just treat shareholders better

First off, go to https://algernonpharmaceuticals.com/ and it even has COVID pictures ..... Taking complete advantage of retail buyers... Then go to their news release

"The company cautions that, while it is preparing to begin phase 2 clinical trials shortly, it is not making any express or implied claims that NP-120 (ifenprodil) is an effective treatment for acute lung injury (ALI), the COVID-19 virus or any other medical condition at this time."



I have added market caps to the BIo Comparables and the reason I put arch is becuase they were 8/10 in the TD top 10 BIO sector pics when i first came to this board when AGN was 9/10. Yet AGN isnt in the top 100 now becuase of the terrible financing.

AGN - NP-120 Phase 2/b3 Clinical Trial - Repurposed Drug

Market Cap - $35,3 Mil
Shares Outstanding - 120,000,000

Warrants Remaining - 40,000,000!!!
Insider Holding - 2%
Insider Buying - $30,000

BLU - Owns a Drug and Commercialization - Phase 3 

Market Cap - 860 MIl
Shares Outstanding - 60,000,000
Warrants Remaining - 0 
Insider Holding - 33%
Insider Buying - $274,000

Lets Throw in ARCH for fun - Metablok Phase 2/b3 Clinical Trial - New Mechanism of action published in CELL. 2 Drugs in Clinical Trials

Market Cap - 83.2 Mil
Shares Outstanding - 58,000,000
Warrants Remaining - 0 
Insider Holding - 55%
Insider Buying - $282,000

Thank you for answering the patent question, have they all just been filed or have any been awarded? Nice videos on the Website also, but if you cant look inward on major issues than I have to ask, Are you an Insider or IR?

Good luck to all , I want you all to make money
<< Previous
Bullboard Posts
Next >>